Introduction {#hyx124s5}
============

Pain is one of the most common and distressing symptoms for cancer patients and a problem for caregivers. Poor control of pain and adverse effects of analgesics may have a great impact on physical functioning, psychological well-being, social activities, and quality of life (QoL).

Although etiologies of cancer pain vary, they can be generally managed with various pharmacological and non-pharmacological interventions ([@hyx124C1]). Although several guidelines for cancer pain control are available, including those published by the World Health Organization ([@hyx124C2]), National Comprehensive Cancer Network ([@hyx124C3]) and European Associations for Palliative Care ([@hyx124C4]), pain control may be ineffective and some patients still suffer from pain ([@hyx124C5]--[@hyx124C7]).

Recently, a pan-European survey of cancer-related pain prevalence found that among patients who had moderate-to-severe pain, 11% (67 of 573) were not receiving analgesia and the percentage was similar across gender (female patients: 11%; male patients: 12%). Consequently, 50% of patients believed that their healthcare professional did not consider their QoL as important, and 12% of them believed that their healthcare professional did not understand that pain was a problem ([@hyx124C8]).

Satisfaction with treatment and healthcare providers is important, as high satisfaction with care may influence the decision to seek care, change providers or medical plans, and treatment adherence ([@hyx124C9]). For patients with chronic diseases, particularly cancer, the patient--physician relationship is important for treatment adherence, and poor care for cancer pain may lead to poor satisfaction. Poor care for cancer pain may be linked to inadequate knowledge of pain treatment, inadequate pain assessment, inaccurate recognition of pain intensity, fear of adverse effects of strong opioids, and regulatory barriers to opioid prescription and dispensing. Moreover, dissatisfaction resulting from poor care may lead to poor patient--physician interactions, resulting in a stressful relationship.

Recently, Taiwanese healthcare organizations have sought to improve the quality of pain management. For example, the Health Promotion Administration developed guidelines for cancer pain management, including careful pain assessment and choice of appropriate therapeutic regimens.

The main objective of this survey was to explore pain management and satisfaction among patients with cancer pain at outpatient departments (OPDs) in various medical centers and regional hospitals to discover real-world satisfaction of pain management in Taiwan after the introduction of cancer-pain management guidelines. The secondary objectives were collecting information on patients' QoL and prescriptions from physicians for management of pain at different intensities.

Materials and methods {#hyx124s6}
=====================

Patient selection {#hyx124s6a}
-----------------

Inclusion criteria were being at least 18 years of age, being diagnosed with cancer, having a prior OPD visit, and proving written informed consent. Exclusion criteria were having a diagnosed or suspected psychotic disorder and/or mental retardation and being unconscious. These inclusion and exclusion criteria have been described in detail in a previous study; the same population was used in the present study ([@hyx124C10]). After obtaining patients' written informed consent at OPD, the questionnaire---on demographic data, current cancer status, pain control medication, characteristics and management of cancer pain, effect of pain on the physical and psychological functioning, pain intensity at the last visit, QoL, analgesic treatment compliance, and satisfaction with pain control, current treatment, and physician---was administered and guidance was provided to all patients. Disease status comprised 'disease free' for no evidence of disease recurrence after curative treatment; 'relief' to imply that the disease was stable involving partial or complete response to palliative treatments; and 'deterioration' to indicate disease progression. One visit was performed in this survey study.

Questionnaires and measures {#hyx124s6b}
---------------------------

The outcome questionnaire was based on the Short version of the Brief Pain Inventory. Patients rated their current pain intensity and worst, lowest and average levels of pain over the 24 h prior to testing using a numeric scale from 0 to 10, to represent 'no pain' and 'pain as bad as you can imagine', respectively. For information on satisfaction about pain control, all participants were asked at OPD by research assistants to answer the following questions: ([@hyx124C1]) How satisfied are you with the way your doctor has treated your pain? ([@hyx124C2]) Are you satisfied with pain control? Responses were scored on a 5-point scale with anchors 'very dissatisfied,' 'not satisfied,' 'fair,' 'satisfied,' and 'very satisfied,' as previously described in detail ([@hyx124C10]).

Since this is a clinical survey, only descriptive data were presented, and no formal statistical considerations were employed in determining sample size.

Statistical analysis {#hyx124s6c}
--------------------

This survey was designed as a non-intervention therapeutic strategy. Data of eligible participants were used for data analysis, as described in detail ([@hyx124C10]). The results were summarized using descriptive statistics. For continuous variables, case number, means and standard deviations were presented. For categorical variables, the number and percentages of subjects in each class were presented. Logistic regression analyses were performed to evaluate whether the interference scale performed identically in the different analgesic ladders. The dependent variables were satisfaction with physicians and treatments in separate analyses. The independent variables were characteristics such as sex, age, primary cancer, use of analgesics, pain intensity and pain interference.

Ethics approval {#hyx124s6d}
---------------

The institutional review board at each hospital in Taiwan---these hospitals are E-Da Hospital, Kaohsiung, Taiwan; Mackay Memorial Hospital, Taipei, Taiwan; Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung, Taiwan; Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan; National Taiwan University Hospital, Taipei, Taiwan; Linko Chang Gung Memorial Hospital, Taoyuan, Taiwan; Wan Fang Hospital, Taipei, Taiwan; Changhua Show-Chwan Memorial Hospital, Changhua, Taiwan; Changhua Christian Hospital, Changhua, Taiwan; Taipei Medical University Hospital, Taipei, Taiwan; Taichung Veterans General Hospital, Taipei, Taiwan; Chia-Yi Christian Hospital, Chiayi, Taiwan; Chiayi Chang Gung Memorial Hospital, Chiayi, Taiwan; China Medical University Hospital, Taichung, Taiwan---granted their approval for aggregated anonymous data to be analyzed and published, and the ethics committee approved this study.

Results {#hyx124s7}
=======

Patient characteristics and dispositions {#hyx124s7a}
----------------------------------------

A total of 2075 patients were enrolled from 14 sites, of which 1051 reported pain within the week prior to the study. Sample derivation is shown in Fig. [1](#hyx124F1){ref-type="fig"}. Participants' characteristics are presented in Table [1](#hyx124TB1){ref-type="table"}. Participants' mean age was 57.47 ± 13.20 years. Breast, head and neck and gastrointestinal cancers---including colorectal cancer---were the most common cancers. More than 50% of subjects were relief from their illness at the time of evaluation. Table 1.Participants' characteristics**Variable*n* (%)**Age, years (mean ± SD)57.47 ± 13.20Gender Male992 (47.81) Female1083 (52.19)Primary cancer Head and neck309 (14.89) Gastrointestinal and colon-rectum394 (18.99) Hepatobiliary and pancreas120 (5.78) Breast527(25.40) Lung and mediastinum184 (8.87) Blood/lymphoma314 (15.18) Gynecological and genitourinary133 (6.41) Others93 (4.48)Disease status Disease free407 (19.61) Relief1226 (59.08) Deterioration442 (21.30)Pain caused by cancer Yes906 (43.66) No564 (27.18) Undetermined605 (29.16)Pain caused by anti-cancer therapy Yes285 (13.73) No1790 (86.27)[^1]

![Flow diagram of patients included in this study.](hyx124f01){#hyx124F1}

Patient compliance {#hyx124s7b}
------------------

When disease status deteriorated, the need for analgesics increased, and pain-related sleep interruptions rose. A total of 768 patients reported needing analgesics in the week prior to testing. Regardless of patients' disease status, more than half needed analgesics before their following treatment session. Higher chances of pain and sleep interruption were reported for participants with deterioration than for other participants (*P* = 0.026; Table [2](#hyx124TB2){ref-type="table"}). Table 2.Compliance by disease statusItemDisease statusDisease free (*N* = 407)Relief (*N* = 1226)Deterioration (*N* = 442)*P* valueReceived analgesics during last week68 (16.71%)426 (34.75%)274 (61.99%)\<0.001Suffered from pain until next treatment^a^36 (52.94%)231 (54.23%)178 (64.96%)0.013Sleep intervention due to receiving analgesics^a^14 (20.59%)86 (20.19%)79 (28.83%)0.026[^2]

### Impact of pain on physical and psychological functioning {#hyx124s7b_1}

Patients with severe pain reported impaired physical and psychological functioning. As patients' level of pain increased, their activity levels decreased, and their moods, interpersonal relationships, sleep and enjoyment of life worsened (*P* \< 0.0001; Table [3](#hyx124TB3){ref-type="table"}). Table 3.The association between pain severity scores and functional interferenceItemsPain average score*P*value\<4 Mean ± SD4--7 Mean ± SD\>7 Mean ± SDPhysical function General activity2.0 ± 2.404.6 ± 2.976.8 ± 3.04\<0.0001 Walking ability1.8 ± 2.543.9 ± 3.125.5 ± 3.54\<0.0001 Normal work2.1 ± 2.744.4 ± 3.296.1 ± 3.62\<0.0001Psychological function Mood2.1 ± 2.384.5 ± 2.816.3 ± 2.79\<0.0001 Relations with people1.6 ± 2.443.3 ± 3.074.7 ± 3.64\<0.0001 Sleep2.2 ± 2.634.3 ± 3.116.7 ± 3.30\<0.0001 Enjoyment of life2.2 ± 2.754.4 ± 3.036.9 ± 2.85\<0.0001[^3]

Patients' satisfaction with physician and treatment {#hyx124s7c}
---------------------------------------------------

Among patients who were satisfied by their treatment, they were almost 100% satisfied with their physicians. When patients believed that their treatments were only fair or were unsatisfactory, they tended to rate their physicians as fair or unsatisfactory. However, regardless of whether patients who still suffered from pain or not, most were satisfied with their physicians. Disease free participants had a higher rate of satisfaction than participants with relieved or deteriorated disease. Other variables---gender, pain etiology and metastasis---led to small differences in satisfaction (Table [4](#hyx124TB4){ref-type="table"}). Interestingly, among patients who complained of pain, only 10 patients felt dissatisfied/very dissatisfied with their treatment; most patients, even those with a pain score over three were satisfied with their treatment (Table [5](#hyx124TB5){ref-type="table"}). Table 4.Patients' satisfaction with physician and treatmentItemSatisfaction with physician*P* valueSatisfied, *N* (%)Fair/dissatisfied, *N* (%)Satisfaction with treatment Satisfied1623 (99.39)10 (0.61)\<0.0001 Fair/dissatisfied53 (11.99)389 (88.01)Pain status Pain831 (79.07)220 (20.93)0.0461 Pain free845 (82.52)179 (17.48)0.1395Sex Male788 (79.44)204 (20.56)0.5894 Female888 (81.99)195 (18.01)0.0004Age (years) ≦50487 (81.99)107 (18.01)0.8254 51--60527 (79.49)136 (20.51)0.0240 61--70367 (79.96)92 (20.04)0.7705 \>70295 (82.17)64 (17.83)Disease status Disease free353 (86.73)54 (13.27) Relief987 (80.51)239 (19.49) Deterioration336 (76.02)106 (23.98)Metastasis No842 (80.96)198 (19.04) Yes834 (80.58)201 (19.42)Pain caused by cancer No471 (83.51)93 (16.49) Yes737 (81.35)169 (18.65) Unknown468 (77.36)137 (22.64)Pain caused by anti-cancer therapy No1444 (80.67)346 (19.33) Yes232 (81.40)53 (18.60)Total1676 (80.77)399 (19.23)Table 5.Average pain score and satisfaction with treatmentSatisfaction with treatmentAverage pain score\<4, *n*(%)4--7, *n*(%)\>7, *n*(%)Very good, *n* = 269148 (28.57)99 (21.57)22 (29.73)Good, *n* = 543278 (53.67)236 (51.42)29 (39.19)Fair, *n* = 22992 (17.76)114 (24.84)23 (31.08)Dissatisfied, *n* = 90 (0.00)9 (1.96)0 (0.00)Very dissatisfied, *n* = 10 (0.00)1 (0.22)0 (0.00)Total, *N* = 1051518 (49.29)459 (43.67)74 (7.04)

Change in analgesic treatment and patients' pain score {#hyx124s7d}
------------------------------------------------------

In order to understand whether doctors listened to their patients and changed analgesics according to the patients' perceptions, we checked previous analgesics ladders for patients who complained of pain (*n* = 1 051). Of these, 518 patients (49.28%) had pain scores of less than four, among whom, 223 patients (43.05%) did not receive any analgesics. Among patients whose pain score was equal to or more than four, 160 patients (15.2%) did not receive any analgesics, including 20 patients whose pain score was more than 7 (Table [6](#hyx124TB6){ref-type="table"}). Table 6.Previous analgesic ladders by average pain scorePrevious treatment ladder (*N*= case number)Pain average score% of all patients who reported pain\<4, *N* (%)4--7, *N* (%)\>7, *N* (%)None (*N* = 383)223 (43.05)140 (30.50)20 (27.03)36.4Adjuvant agents only (*N* = 54)36 (6.95)16 (3.49)2 (2.70)5.1Ladder 1 (*N* = 167)83 (16.02)73 (15.90)11 (14.86)15.9Ladder 2 (*N* = 244)107 (20.66)119 (25.93)18 (24.32)23.2Ladder 3 (*N* = 203)69 (13.32)111 (24.18)23 (31.08)19.3Total *N* = 1051518 (49.28)459 (43.67)74 (7.04)100

In order to determine whether oncologists in Taiwan altered analgesic treatments when their patients complained of poor control of pain, we assessed changes in analgesics at their last visit against patients' average pain score, we found that more than 70% of doctors did not change previously prescribed analgesics based on patients' current pain status (Table [7](#hyx124TB7){ref-type="table"}). Table 7.Change of analgesics by average pain scorePain average scoreDecreased ladder, *N* (%)Unchanged, *N* (%)Increased ladder, *N* (%)≤3 (*N* = 518)82 (15.83)389 (75.10)47 (9.07)4--7 (*N* = 459)56 (12.20)342 (74.51)61 (13.29)\>7 (*N* = 74)10 (13.51)52 (70.27)12 (16.22)Total (*N* = 1051)148 (14.08)783 (74.50)120 (11.42)

Discussion {#hyx124s8}
==========

The first published multi-center study on satisfaction with pain control among cancer patients in Taiwan reported that while 54% of patients from oncology OPDs reported pain, only 58% of these patients received analgesics. Nonetheless, most of the patients (64%) reported being satisfied or very satisfied with pain control ([@hyx124C7]). In the current prospective study, we attempted to investigate the status, characteristics and management of cancer pain after the introduction of guidelines, education and training programs.

As expected, before the week of study, patients with deteriorated status received more analgesics than patients who were at other disease status. However, more than one-third of patients who were at relief status still needed analgesics, and more than 50% experienced pain even if they had already received analgesics. Further, patients with deterioration reported more sleep interruptions (Table [2](#hyx124TB2){ref-type="table"}). This suggests that close monitoring, follow-ups and evaluations are important for patients receiving analgesics, especially those patients whose diseases are worsening. Even for disease-free or improving cases, disease- or treatment-related pain could lower QoL. Another issue is whether analgesic intake is regular or only when pain presents. Liang et al. found that adherence to prescribed opioids among Taiwanese oncology outpatients was 63.6% and 30.9% for around-the-clock and as-needed opioid analgesics, respectively ([@hyx124C11]). A better understanding of barriers to analgesic adherence and improvement efforts is needed.

Unexpectedly, although pain control was not good for most patients, a high percentage of patients experiencing pain still expressed satisfaction with their physicians (79.07%) compared with those who gave fair/dissatisfied ratings (20.93%, Table [4](#hyx124TB4){ref-type="table"}). Beck et al. have also reported the coexistence of high levels of satisfaction and pain: 22% of the advanced-cancer group reported severe pain frequently or constantly and 83% of the advanced-cancer group reported being very satisfied or satisfied with their pain management ([@hyx124C12]). In another study of 72 surgical patients, the mean severest pain score in the previous 24 h was 7.56. More than 70% reported a score of seven or greater, but more than 70% of the patients also reported that they were very satisfied (20%) or satisfied (51%) with their pain relief ([@hyx124C13]). Nonetheless, dissatisfied patients showed a significantly higher average pain level compared with satisfied patients ([@hyx124C9]). Breivik found that average or poor pain control may interfere with patients' QoL ([@hyx124C8]). This paradox of high pain and high satisfaction could mislead physicians in their assessments, potentially leading to under-treatment of pain.

Regarding satisfaction with physicians, a high percentage of patients at different pain intensities were satisfied with their treatment, but the number of patients who were dissatisfied or rated their treatment as fair increased with increases in pain scores (Table [5](#hyx124TB5){ref-type="table"}).

Moreover, although there were 1051 patients in our study (50.65% of all patients) who reported pain within the past week, not all of them had good control of pain; 160 patients (15.2% of all patients) with a pain score of more than three did not receive analgesic or adjuvant treatment (Table [6](#hyx124TB6){ref-type="table"}). This is consistent with Breivik's pan-European survey wherein 11% of all patients did not receive any analgesic medication for their pain. These similar results indicate that even after years of education and the introduction of guidelines in Taiwan, assessments are often not adequate and frequently result in suboptimal treatment and outcomes. Moreover, such treatment issues are rather universal ([@hyx124C6],[@hyx124C8],[@hyx124C14],[@hyx124C15]), they occur more commonly for elderly patients ([@hyx124C15]) and minority ([@hyx124C16]). Moreover, 40% of all cancer patients lack the resources to effectively manage their pain ([@hyx124C17]). Thus, both patients and doctors should be considered responsible for inadequate treatment.

For example, patients may not report their pain regularly; may be afraid of side effects of analgesics, especially opioids, of addiction, and of distracting the physician from treating the underlying medical condition ([@hyx124C18]); or may believe that pain is an inevitable consequence of cancer ([@hyx124C19]). Thus, information given to doctors will be insufficient for making correct judgments.

On the other hand, doctors fail to appreciate the intensity of pain may lead to poor pain control. Doctors should be able to evaluate current disease status and the extent and severity of cancer-related pain. Communication is important for patient-centered care and addressing misconceptions, fears, or uncertainty. Doctors' empathy, effective communication, responsiveness to patients' opinions and perceptions, and inclusion of patients in treatment are associated with better treatment outcomes ([@hyx124C20]).

Why doctors cannot well adjust analgesics according to the patient's experience of pain? It might also be because of a lack of familiarity with analgesics, fewer choices of analgesics, lack of empathy, fear of addiction or dependence, and regulatory barriers to opioid prescription and dispensing. Thus, the barriers to pain control can also stem from physicians.

The poor improvement in the control of cancer pain might also come from high pain intensity, high comorbidity, and low treatment motivation. The consequences of inappropriate pain assessments and poor communication between patients and physicians may explain why 70% of the physicians in our study did not change analgesics for patients whose previous pain score was greater than three, and why more than 10% of doctors reduced analgesic treatment strength for patients who still had severe pain (Table [7](#hyx124TB7){ref-type="table"}). Unfortunately, most physicians in Taiwan who prescribe pain medications are overworked at OPD and do not have enough time to administer lengthy assessment tools to determine their patients' adherence to analgesics. Physicians need to assign time to discuss cancer pain with their patients, individualize pain management medications, and improve each patient's perception of control, thereby improving self-efficacy in health and pain management ([@hyx124C21]).

High satisfaction with care may influence decisions to seek care, change providers or medical plans, and adhere to prescribe treatment plans. Several factors may influence patients' satisfaction with pain control, such as the stage of cancer, communication between patients and healthcare providers, management of side effects, efficacy of medications, and support from family and society ([@hyx124C12]). In Sherwood et al.'s study on 241 in-hospital patients, including those with postoperative pain and cancer, four distinct themes affecting patient satisfaction were identified: pain experience, view of providers, pain management experiences, and pain management outcomes. High satisfaction was directly linked to the doctor's or nurse's ability to identify pain management as an important goal and to decreases in pain over the previous year ([@hyx124C22]).

In our study, we confirmed that pain could influence patients' QoL, as poor pain control was linked to poor sleep quality and poorer daily functioning. Although we found that most cancer patients at OPDs were satisfied with their physicians, this did not mean that patients had good control of pain. On the contrary, despite the years of education on cancer pain management, more than 50% of patients still did not have adequate control of their pain, and most physicians did not change or increase analgesics for pain alleviation, suggesting that educational efforts should involve both healthcare providers and patients, and the content should include the nature and management of cancer pain; the side effects from different types of management---especially analgesics---and ways to handle them; and development of empathy, interaction, and communication skills through palliative care training ([@hyx124C23]). Thus, physicians must listen to patients' descriptions to better investigate the causes of pain and provide effective treatments.

In our study, 20% of cancer survivors reported pain at oncological OPDs. They require different supports because of their long lifespans, implying that pain control is critical for their QoL.

Conclusion {#hyx124s9}
==========

Although more than 75% of the OPD patients with cancer pain in this study reported satisfaction with their physician and pain management, most physicians did not change the prescribed analgesics according to patients' current pain status. In order to achieve good control over cancer pain and consequently, satisfaction, strategies to ensure adequate reporting, good doctor--patient communication, thorough assessments of disease status, and familiarity with analgesics are essential. Further, cancer pain control evaluations should be conducted regularly.
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[^1]: SD, standard deviation.

[^2]: ^a^Calculated for subjects who received analgesics during the week prior to testing.

[^3]: SD, standard deviation.
